Related Experiment Videos
Childhood bullous pemphigoid. Clinical and immunologic features, treatment, and prognosis
A J Nemeth1, A D Klein, E W Gould
1Department of Dermatology, Cutaneous Surgery, University of Miami School of Medicine, FL 33101.
Insights
This study reports the youngest infant diagnosed with childhood bullous pemphigoid, a rare blistering skin disorder. Type IV collagen mapping aided diagnosis, distinguishing it from epidermolysis bullosa acquisita.
Area of Science:
- Pediatric Dermatology
- Immunodermatology
- Histopathology
Background:
- Childhood bullous pemphigoid (cBP) is a rare autoimmune blistering disease.
- Distinguishing cBP from other blistering disorders like epidermolysis bullosa acquisita (EBA) is crucial for appropriate management.
- Early diagnosis and characterization are essential for understanding the prognosis of this rare condition.
Observation:
- A 2 1/2-month-old female infant presented with tense bullae on her hands and feet.
- Clinical presentation suggested a blistering disorder of the skin.
Findings:
- Biopsy specimens confirmed childhood bullous pemphigoid.
- Type IV collagen mapping of the basement membrane zone was utilized for diagnostic confirmation.
- This technique effectively differentiated childhood bullous pemphigoid from childhood epidermolysis bullosa acquisita.
- The patient represents the youngest reported case of childhood bullous pemphigoid.
Implications:
- This case highlights the importance of considering cBP in infants with blistering disorders.
- Type IV collagen mapping is a valuable tool for diagnosing cBP in pediatric patients.
- Further research into the clinical and immunological features, treatment, and prognosis of cBP is warranted.
Abstract:
A 2 1/2-month-old female infant presented with multiple tense bullae on the hands and feet. Analysis of biopsy specimens confirmed our clinical impression of childhood bullous pemphigoid. Confirmatory data included type IV collagen mapping of the basement membrane zone, a readily available technique that helps distinguish childhood bullous pemphigoid from childhood epidermolysis bullosa acquisita. To our knowledge, our patient is the youngest described with childhood bullous pemphigoid, and we use this opportunity to review the literature and examine the clinical and immunologic features, treatment, and prognosis of this rare childhood immunobullous disorder.